Related Experiment Video
Updated: Feb 15, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
LRP6 targeting suppresses gastric tumorigenesis via P14ARF-Mdm2-P53-dependent cellular senescence
Haibin Wang1, Guoxing Xu2, Zhengjie Huang1,3
1Department of Gastrointestinal Surgery, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen 361003, Fujian, China.
Abstract:
NLRP6, a member of the Nod-like receptor family, protects against chemically induced intestinal injury and colitis-associated colon cancer. However, the cellular mechanisms involved in this NLRP6-mediated protection remain unclear. Here, we show that NLRP6 was down-regulated in approximately 75% of primary gastric cancer cases and exhibited significant associations with advanced clinical-stage lymph node metastasis and poor overall survival. Functional studies established that ectopic overexpression or down-regulation of NLRP6 inhibited cancer cell proliferation by inducing cell cycle arrest at the G1 phase via P21 and Cyclin D1 both in vitro and in vivo. Activation of the P14ARF-P53 pathway played a crucial role in the observed cellular senescence. We further demonstrated that ectopic overexpression of NLRP6 combined with inactivation of NF-κB(p65) and Mdm2 activates P14ARF-P53 to promote the senescence of gastric cancer cells. These findings indicate that NLRP6 functions as a negative regulator of gastric cancer and offer a potential new option for preventing gastric cancer.
Insights
NLRP6 (Nod-like receptor family, pyrin domain containing 6) acts as a tumor suppressor in gastric cancer. Its down-regulation correlates with poor survival, and restoring NLRP6 induces cancer cell cycle arrest and senescence.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- NLRP6 (Nod-like receptor family, pyrin domain containing 6) is known for its protective role in intestinal injury and colitis-associated colon cancer.
- The precise cellular mechanisms underlying NLRP6-mediated protection, particularly in gastric cancer, are not fully understood.
Purpose of the Study:
- To investigate the role of NLRP6 in gastric cancer development and progression.
- To elucidate the cellular mechanisms by which NLRP6 influences gastric cancer cell behavior.
Main Methods:
- Analysis of NLRP6 expression in primary gastric cancer tissues.
- In vitro and in vivo functional studies involving ectopic NLRP6 overexpression or down-regulation.
- Cell cycle analysis, western blotting, and assessment of senescence pathways (P14ARF-P53, NF-κB(p65), Mdm2).
Main Results:
- NLRP6 was down-regulated in approximately 75% of gastric cancer cases, associated with lymph node metastasis and poor survival.
- NLRP6 overexpression or down-regulation inhibited gastric cancer cell proliferation by inducing G1 phase cell cycle arrest via P21 and Cyclin D1.
- Activation of the P14ARF-P53 pathway was crucial for NLRP6-induced cellular senescence, further enhanced by NF-κB(p65) and Mdm2 inactivation.
Conclusions:
- NLRP6 functions as a negative regulator of gastric cancer.
- Restoring NLRP6 expression can induce gastric cancer cell senescence, presenting a potential therapeutic strategy.
Related Concept Videos
Replicative Cell Senescence
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
Frequency-dependent Selection
Drug Dependence

